Vanhove Geertrui
SEC CIK 1771994 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRZN | Surrozen, Inc./DE | Chief Medical Off | 32.4K | — | — | 1 | 2022-12-15 | 2022-12-15 |
Most active insiders at SRZN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TCG Crossover GP II, LLC | 10% | — | $6.91M |
| 2 | Kutzkey Tim | Dir, 10% | $5.98M | — |
| 3 | COLUMN GROUP III GP, LP | 10% | $4.99M | — |
| 4 | TCG Crossover Fund II, L.P. | 10% | $4.68M | — |
| 5 | Column Group Opportunity III GP, LP | 10% | $641.6K | — |
| 6 | TCG Opportunity III GP, LLC | 10% | $357.3K | — |
| 7 | TCG Crossover GP III, LLC | 10% | $202.5K | — |
| 8 | Parker Craig C | CEO, Dir | — | $150.8K |
| 9 | Williams Charles O | COO | — | $99.0K |
| 10 | Li Yang | Exec. VP, Research | — | $75.0K |
Vanhove Geertrui made no open-market trades at SRZN in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-19 | 2022-12-15 | SRZN | Surrozen, Inc./DE | Vanhove Geertrui | Chief Medical Off | A - Grant | $0.41 | +9,578 | 32.4K | +42% | +$3,927 |
Purchase Sale Sale after option exercise All abbreviations